28 Predictions of outcomes and benefit of immune checkpoint inhibitor treatment in NSCLC require information on both tumor and host biology

oleh: Joanna Roder, Heinrich Roder, Senait Asmellash, Minu Srivastava, Wei Zou, Mark McCleland, David Shames, Laura Maguire, Steven Rightmyer, Patrick Norman, Lelia Net, Thomas Campbell, Robert Georgantas

Format: Article
Diterbitkan: BMJ Publishing Group 2021-11-01

Deskripsi

No description available for this item.